65 related articles for article (PubMed ID: 24938897)
1. Papanicolaou tests with coexisting squamous and glandular abnormalities.
Khor LY; Abdul-Karim FW; Bruening AE; Weber Noffsinger DK; Booth CN
Cancer Cytopathol; 2014 Aug; 122(8):620-6. PubMed ID: 24938897
[TBL] [Abstract][Full Text] [Related]
2. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the papanicolaou smear.
van Aspert-van Erp AJ; Smedts FM; Vooijs GP
Cancer; 2004 Aug; 102(4):210-7. PubMed ID: 15368312
[TBL] [Abstract][Full Text] [Related]
3. Cervical screening test results associated with 265 histopathologic diagnoses of cervical glandular neoplasia.
Zhao C; Li Z; Austin RM
Am J Clin Pathol; 2013 Jul; 140(1):47-54. PubMed ID: 23765533
[TBL] [Abstract][Full Text] [Related]
4. The Cellient automated cell block system is useful in the differential diagnosis of atypical glandular cells in Papanicolaou tests.
Xing W; Hou AY; Fischer A; Owens CL; Jiang Z
Cancer Cytopathol; 2014 Jan; 122(1):8-14. PubMed ID: 23963870
[TBL] [Abstract][Full Text] [Related]
5. The pathological outcome of ThinPrep Pap tests diagnosed as glandular cell abnormalities alone versus combined glandular and squamous abnormalities.
Harbhajanka A; Chahar S; Michael CW
Diagn Cytopathol; 2019 Feb; 47(2):88-93. PubMed ID: 30451396
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of atypical glandular cells of undetermined significance in postmenopausal women.
Chhieng DC; Elgert P; Cohen JM; Cangiarella JF
Cancer; 2001 Feb; 93(1):1-7. PubMed ID: 11241259
[TBL] [Abstract][Full Text] [Related]
7. Severe cervical glandular cell lesions with coexisting squamous cell lesions.
van Aspert-van Erp AJ; Smedts FM; Vooijs GP
Cancer; 2004 Aug; 102(4):218-27. PubMed ID: 15368313
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance of atypical glandular cells on cervicovaginal Pap smears.
Kim MK; Lee YK; Hong SR; Lim KT
Diagn Cytopathol; 2017 Oct; 45(10):867-872. PubMed ID: 28771986
[TBL] [Abstract][Full Text] [Related]
9. Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria.
Thrall MJ; Pambuccian SE; Stelow EB; McKeon DM; Miller L; Savik K; Gulbahce HE
Cancer; 2008 Jun; 114(3):171-9. PubMed ID: 18454461
[TBL] [Abstract][Full Text] [Related]
10. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
Li Z; Austin RM; Guo M; Zhao C
Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of atypical glandular cells (AGC) classification: cytohistologic comparison and relationship to HPV results.
Diaz-Montes TP; Farinola MA; Zahurak ML; Bristow RE; Rosenthal DL
Gynecol Oncol; 2007 Feb; 104(2):366-71. PubMed ID: 17049972
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
[TBL] [Abstract][Full Text] [Related]
13. Glandular epithelial abnormalities on thinprep® pap tests: Clinical and cytohistologic correlation.
Selvaggi SM
Diagn Cytopathol; 2016 May; 44(5):389-93. PubMed ID: 26878832
[TBL] [Abstract][Full Text] [Related]
14. Cytological aspects of uterine cervical adenocarcinoma, adenosquamous carcinoma and combined adenocarcinoma-squamous carcinoma: appraisal of diagnostic criteria for in situ versus invasive lesions.
Hayes MM; Matisic JP; Chen CJ; Mohamed A; Anderson GH; LeRiche JC; Amy R
Cytopathology; 1997 Dec; 8(6):397-408. PubMed ID: 9439892
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
[TBL] [Abstract][Full Text] [Related]
16. The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population.
Chin AB; Bristow RE; Korst LM; Walts A; Lagasse LD
Am J Obstet Gynecol; 2000 Jun; 182(6):1278-82. PubMed ID: 10871439
[TBL] [Abstract][Full Text] [Related]
17. ThinPrep Pap Test promotes detection of glandular lesions of the endocervix.
Bai H; Sung CJ; Steinhoff MM
Diagn Cytopathol; 2000 Jul; 23(1):19-22. PubMed ID: 10907926
[TBL] [Abstract][Full Text] [Related]
18. Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: a comparison.
Chacho MS; Mattie ME; Schwartz PE
Cancer; 2003 Jun; 99(3):135-40. PubMed ID: 12811853
[TBL] [Abstract][Full Text] [Related]
19. Challenges in the Pap diagnosis of endocervical adenocarcinoma in situ.
Niu S; Molberg K; Thibodeaux J; Rivera-Colon G; Hinson S; Zheng W; Lucas E
J Am Soc Cytopathol; 2019; 8(3):141-148. PubMed ID: 31097290
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinoma in situ of the cervix: management and outcome.
Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
